Warfarin and royal jelly interaction.

Abstract:

:An 87-year-old African-American man came to the internal medicine clinic for a routine anticoagulation management visit. He had no complaints. His medical history was significant for stage IV-A follicular non-Hodgkin's lymphoma, atrial fibrillation, and hypertension. His long-term drug therapy consisted of warfarin, felodopine, lisinopril-hydrochlorothiazide, controlled-release diltiazem, potassium chloride, and oxycodone. He reported adherence with his prescribed drugs and denied taking any over-the-counter or herbal products. Overall, the patient's drug therapy had been consistent during the preceding 3 months, no significant changes had occurred in his clinical status, and no significant changes had been noted in his diet; his international normalized ratio (INR) had ranged from 1.9-2.4 (therapeutic range 2-3). He denied tobacco use, alcohol consumption, and recent travel. Four weeks later, the patient came to the emergency department with hematuria. He denied dysuria, taking more than the prescribed amount of warfarin, any changes in his diet, taking any over-the-counter or herbal products, and any other bleeding. On admission to the hospital, his INR was 6.88, which increased to 7.29 during his hospital stay. On further investigation, the patient admitted that he had started taking an herbal supplement, royal jelly, 1 week earlier. When asked specifically about the ingredients in the supplement, he stated that royal jelly was the only component. Relative to the patient's denial of any other changes in his condition or drug regimen, the most probable explanation for his elevated INR and subsequent bleeding is a possible interaction between royal jelly and warfarin. To our knowledge, no case reports concerning royal jelly and warfarin taken concomitantly have been reported. Clinicians should be proactive and repeatedly provide education regarding the potential dangers of dietary supplements taken with conventional drugs.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Lee NJ,Fermo JD

doi

10.1592/phco.26.4.583

subject

Has Abstract

pub_date

2006-04-01 00:00:00

pages

583-6

issue

4

eissn

0277-0008

issn

1875-9114

journal_volume

26

pub_type

杂志文章
  • Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection.

    abstract::The effects of proton pump inhibitors on the pharmacokinetics of atazanavir and amprenavir (administered as fosamprenavir) were rigorously evaluated in healthy volunteers in two studies, but formal studies in persons infected with human immunodeficiency virus (HIV) are lacking. We describe a 65-year-old man with HIV w...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.4.511

    authors: Kiser JJ,Lichtenstein KA,Anderson PL,Fletcher CV

    更新日期:2006-04-01 00:00:00

  • Simvastatin-associated memory loss.

    abstract::The statins are widely used to treat dyslipidemias. They are generally associated with mild adverse effects, but rarely, more serious reactions may occur. A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was switched to pravastatin, ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.7.767.34577

    authors: Orsi A,Sherman O,Woldeselassie Z

    更新日期:2001-06-01 00:00:00

  • Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.

    abstract:STUDY OBJECTIVE:Bevacizumab is used in the treatment of recurrent glioblastoma, but evidence is limited on the incidence of thromboembolic complications regarding the use of this drug in real-world settings. We evaluated the risk of arterial thromboembolism (ATE) and venous thromboembolism (VTE) associated with the use...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2310

    authors: Lee I,Adimadhyam S,Nutescu EA,Zhou J,Asfaw AA,Sweiss KI,Patel PR,Calip GS

    更新日期:2019-09-01 00:00:00

  • Making progress in the management of postoperative pain: a review of the cyclooxygenase 2-specific inhibitors.

    abstract::Postoperative pain is one of the most common forms of acute pain. Optimal pain management decreases the stress response to surgery, reduces complications, improves recovery time, and results in improved economic and quality-of-life outcomes. A preoperative, multimodal approach to postoperative analgesia can be achieve...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.17.1714.52339

    authors: Stephens JM,Pashos CL,Haider S,Wong JM

    更新日期:2004-12-01 00:00:00

  • Tacrolimus toxicity associated with concomitant metoclopramide therapy.

    abstract::Subtherapeutic tacrolimus trough concentrations were noted in a 52-year-old woman who had undergone liver transplantation. Her tacrolimus dosage was increased from 7 to 28 mg twice/day, and ketoconazole therapy was added; however, her tacrolimus concentration remained undetectable. Metoclopramide 10 mg 4 times/day was...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.5.532.33357

    authors: Prescott WA Jr,Callahan BL,Park JM

    更新日期:2004-04-01 00:00:00

  • The pharmacologic activity of ketorolac tromethamine.

    abstract::Ketorolac tromethamine is a highly potent member of a class of compounds having both analgesic and antiinflammatory activity. In animal pain models using underlying inflammation, ketorolac markedly inhibited the pain response and increased the pain threshold; it did not exhibit any narcotic or central nervous system d...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Rooks WH 2nd

    更新日期:1990-01-01 00:00:00

  • Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.

    abstract:STUDY OBJECTIVE:To evaluate the hemodynamic and electrocardiographic effects of a single dose of commercially available bitter-orange dried-fruit extract, which is increasingly being used in dietary supplements. DESIGN:Randomized, double-blind, placebo-controlled, crossover study. SETTING:University of Connecticut, S...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1592/phco.2005.25.12.1719

    authors: Min B,Cios D,Kluger J,White CM

    更新日期:2005-12-01 00:00:00

  • Asian and Asian-American college students' awareness of osteoporosis.

    abstract:STUDY OBJECTIVE:To quantify Asian and Asian-American college students' knowledge of osteoporosis and preventive health behaviors. DESIGN:Sixty-four-question survey SETTING:University of Minnesota. SUBJECTS:One hundred sixty-eight male and female Asian and Asian-American students, mean age 21 +/- 3.4 years. MAIN RES...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.12.1047.33608

    authors: Nguyen DN,O'Connell MB

    更新日期:2002-08-01 00:00:00

  • Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction.

    abstract::Ceftazidime, a beta-lactamase-stable, third-generation cephalosporin, is widely used for the treatment of serious gram-negative infections. Neurotoxicity has rarely been associated with the drug; however, two of our patients developed ceftazidime-induced neurotoxicity that produced confusion, disorientation, agitation...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Slaker RA,Danielson B

    更新日期:1991-01-01 00:00:00

  • Omadacycline Enters the Ring: A New Antimicrobial Contender.

    abstract::Omadacycline is a novel aminomethylcycline approved for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. This article reviews existing data pertaining to the biochemistry, mechanism of action, pharmacokinetics/pharmacodynamics, in vitro activity, and curre...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2185

    authors: Barber KE,Bell AM,Wingler MJB,Wagner JL,Stover KR

    更新日期:2018-12-01 00:00:00

  • Therapy with macrolides in patients with cystic fibrosis.

    abstract::Cystic fibrosis affects 1/2500 individuals and is the most common lethal autosomal recessive disease in people of northern European descent. It is characterized by chronic infections with mucoid Pseudomonas aeruginosa and progressive deterioration of respiratory function. Much research has focused on the inflammatory ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.3.227.33544

    authors: Gaylor AS,Reilly JC

    更新日期:2002-02-01 00:00:00

  • Strategies in the management of acute myocardial infarction.

    abstract::Clinical trials continue to evaluate the pharmacologic management of myocardial infarction for benefits in mortality, degree of infarct artery patency, and frequency of reocclusion. The discovery of thrombus formation in the development of the myocardial infarction renewed interest in thrombolytic therapy. In appropri...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Talbert RL

    更新日期:1996-09-01 00:00:00

  • Updates in hormonal emergency contraception.

    abstract::In recent years, there have been many updates in hormonal emergency contraception. Levonorgestrel emergency contraception has been available for several years to prevent pregnancy when used within 72 hours after unprotected intercourse or contraceptive failure, and it was recently approved for nonprescription status f...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.9.887

    authors: Shrader SP,Hall LN,Ragucci KR,Rafie S

    更新日期:2011-09-01 00:00:00

  • Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.

    abstract::Oral anticoagulation with warfarin requires routine monitoring of prothrombin time, expressed as the international normalized ratio (INR). Patient self-testing for INR is common in Europe but not in the United States. In order to determine the frequency of INR self-testing among patients whose anticoagulant therapy is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.2.265.56949

    authors: Wittkowsky AK,Sekreta CM,Nutescu EA,Ansell J

    更新日期:2005-02-01 00:00:00

  • Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.

    abstract:STUDY OBJECTIVE:Evaluate dabigatran adverse event reports with a reported bleeding event and/or reported fatal outcome compared with warfarin. DESIGN:Retrospective analysis of the FDA Adverse Event Reporting System (FAERS) database. MEASUREMENTS AND MAIN RESULTS:We identified reports from October 1, 2010, through Dec...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1415

    authors: McConeghy KW,Bress A,Qato DM,Wing C,Nutescu EA

    更新日期:2014-06-01 00:00:00

  • Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.

    abstract:STUDY OBJECTIVE:To determine if development of acneiform rash is a predictor of objective response rate with lapatinib. DESIGN:Subanalysis of data from a prospective, phase II study. SETTING:Academic breast care clinic. PATIENTS:Forty-nine treatment-naïve patients with human epidermal growth factor receptor-2 (HER2)...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1308

    authors: Parma J,Pavlick A,Schiff R,Osborne CK,Chang JC,Rimawi M,Trivedi MV

    更新日期:2013-10-01 00:00:00

  • Falsely decreased total serum calcium concentration associated with iron dextran injection.

    abstract::We cared for a patient in whom iron dextran administration interfered with the determination of total serum calcium concentration. An unexpected elevation in serum phosphorus concentration also occurred after the iron dextran infusion. A MEDLINE search from 1966 to present was conducted, and the manufacturer of the ir...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Newsom L,Erstad BL,Nakazato PZ,Daller JA

    更新日期:1995-11-01 00:00:00

  • Symptomatic cardiotoxicity associated with 5-fluorouracil.

    abstract::A prospective cohort study was conducted in 35 hospitals with oncology units to determine the incidence of symptomatic cardiotoxicity in patients receiving continuous infusions of 5-fluorouracil (5-FU), and to identify risk factors that could contribute to the development of 5-FU-associated cardiotoxicity. A sample of...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Meyer CC,Calis KA,Burke LB,Walawander CA,Grasela TH

    更新日期:1997-07-01 00:00:00

  • Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists.

    abstract::A formerly infrequently isolated strain of Clostridium difficile known as BI/NAP1 has resulted in geographically diverse outbreaks of C. difficile-associated disease. Such rapid dissemination and distribution of an outbreak strain of C. difficile are unprecedented, with many regions across North America, as well as se...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.26.3.299

    authors: Owens RC

    更新日期:2006-03-01 00:00:00

  • Concomitant therapy with anxiolytics or hypnotics and maintenance of initial SSRI therapy.

    abstract::We conducted a retrospective analysis to evaluate the relationship between anxiolytic or hypnotic therapy and maintenance of therapy with selective serotonin reuptake inhibitors (SSRIs). Subjects were 654 patients who received anxiolytics or hypnotics early in SSRI therapy (study group ) and 15,172 patients who did no...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Shields SA,Gregor KJ,Young CH,James SP

    更新日期:1998-11-01 00:00:00

  • Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin.

    abstract::Dabigatran, a direct thrombin inhibitor, is an oral anticoagulant indicated for the prevention of stroke in patients with atrial fibrillation (AF) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. Dabigatran, as well as the other new anticoagulants-rivaroxaban, apixaban, and edoxaban...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1698

    authors: Wiggins BS,Northup A,Johnson D,Senfield J

    更新日期:2016-02-01 00:00:00

  • Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.

    abstract:BACKGROUND:Modification of guideline-directed medical therapy (GDMT) in hospitalized patients with heart failure (HF) has not been extensively evaluated. METHODS:The community surveillance arm of the Atherosclerosis Risk in Communities Study identified 6959 HF hospitalizations from 2005-2011. Predictors of GDMT modifi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.2091

    authors: Tran RH,Aldemerdash A,Chang P,Sueta CA,Kaufman B,Asafu-Adjei J,Vardeny O,Daubert E,Alburikan KA,Kucharska-Newton AM,Stearns SC,Rodgers JE

    更新日期:2018-04-01 00:00:00

  • Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.

    abstract::Hypoactive sexual desire disorder (HSDD) affects nearly 1 in 10 women. Thus, it is essential for pharmacists and other health care providers to be comfortable when discussing a patient's sexual health to ensure appropriate triage so that the specific causes of HSDD can be identified and potential recommendations provi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1209

    authors: Lodise NM

    更新日期:2013-04-01 00:00:00

  • Selecting a decongestant.

    abstract::Antihistamines and decongestants often are used interchangeably and in combination for a variety of upper respiratory illnesses ranging from allergic rhinitis to the common cold; yet, these two classes of drugs have distinct therapeutic actions. When administered alone, antihistamines are of no value in reducing nasal...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Hendeles L

    更新日期:1993-11-01 00:00:00

  • Effect of Neuromuscular Blocking Agents on Sedation Requirements in Trauma Patients with an Open Abdomen.

    abstract::The appropriate level of sedation in patients with an open abdomen following damage control laparotomy (DCL) is debated. Chemical paralysis with neuromuscular blocking agents (NMBAs) has been used to decrease time to abdominal closure. We sought to evaluate the effect of NMBA use on sedation requirements in patients w...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2225

    authors: Smith SE,Hamblin SE,Dennis BM

    更新日期:2019-03-01 00:00:00

  • The effect of theophylline on respiratory muscle contractility and fatigue.

    abstract::The traditional role of theophylline as a bronchodilator has been expanded by recent findings that suggest this drug has more than smooth muscle relaxant properties. Several investigators indicate that theophylline has an inotropic effect on respiratory muscle, causing enhanced muscular contraction and prevention of m...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Landsberg KF,Vaughan LM,Heffner JE

    更新日期:1990-01-01 00:00:00

  • Enoxaparin use in the neonatal intensive care unit: experience over 8 years.

    abstract:STUDY OBJECTIVE:To evaluate the effectiveness and safety of enoxaparin therapy in a neonatal intensive care unit (NICU). DESIGN:Retrospective chart review. SETTING:Level III NICU in a Canadian academic center. PATIENTS:All neonates treated with enoxaparin while in the NICU between January 1, 1998, and June 1, 2006. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.9.1263

    authors: Malowany JI,Knoppert DC,Chan AK,Pepelassis D,Lee DS

    更新日期:2007-09-01 00:00:00

  • Methotrexate in rheumatoid arthritis: an update.

    abstract::Methotrexate, a folic acid antagonist, is being employed more frequently in an attempt to control rheumatoid arthritis that has not responded adequately to conventional therapies. Systemic administration of 7.5-15 mg weekly in a pulse fashion appears to be effective without precipitating serious adverse effects. Conce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1986.tb03472.x

    authors: Miller DR,Letendre PW,DeJong DJ,Fiechtner JJ

    更新日期:1986-07-01 00:00:00

  • Use of Newer Anticonvulsants for the Treatment of Status Epilepticus.

    abstract::Status epilepticus (SE) has a high mortality rate and is one of the most common neurologic emergencies. Fast progression of this neurologic emergency and lack of response to traditional antiepileptic drugs (AEDs) in most cases has challenged clinicians to use new agents. This article evaluates the efficacy and safety ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2229

    authors: Farrokh S,Bon J,Erdman M,Tesoro E

    更新日期:2019-03-01 00:00:00

  • Propafenone-theophylline interaction.

    abstract::A 63-year-old man with ventricular tachycardia (VT) refractory to drug therapy was admitted for surgical ablation of the VT with coronary artery bypass graft surgery. He developed increased theophylline concentrations with decreased calculated theophylline clearance after propafenone therapy for recurrent VT was initi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Spinler SA,Gammaitoni A,Charland SL,Hurwitz J

    更新日期:1993-01-01 00:00:00